Evidence map›Paper›PMID 37898772›Full record

Trial reportBMC neurology2023

Multimodal agility-based exercise training (MAT) versus strength and endurance training (SET) to improve multiple sclerosis-related fatigue and fatigability during inpatient rehabilitation: a randomized controlled pilot and feasibility study [ReFEx].

Florian Wolf, Jörn Nielsen, Jochen Saliger, Eva Hennecken, Philipp Kröber, Mareike Eschweiler, Ann-Kristin Folkerts, Hans Karbe, Philipp Zimmer

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Florian WolfNeurological Rehabilitation Center Godeshoehe GmbH, Bonn, Germany. florian.wolf@go.johanniter-kliniken.de.
Jörn NielsenNeurological Rehabilitation Center Godeshoehe GmbH, Bonn, Germany.
Jochen SaligerNeurological Rehabilitation Center Godeshoehe GmbH, Bonn, Germany.
Eva HenneckenNeurological Rehabilitation Center Godeshoehe GmbH, Bonn, Germany.
Philipp KröberNeurological Rehabilitation Center Godeshoehe GmbH, Bonn, Germany.
Mareike EschweilerNeurological Rehabilitation Center Godeshoehe GmbH, Bonn, Germany.
Ann-Kristin FolkertsDepartment of Medical Psychology | Neuropsychology and Gender Studies, Center for Neuropsychological Diagnostics and Intervention (CeNDI), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Hans KarbeNeurological Rehabilitation Center Godeshoehe GmbH, Bonn, Germany.
Philipp ZimmerDivision of Performance and Health, Institute for Sport and Sport Science, Technical University Dortmund, Dortmund, Germany.
Institute for Sports Medicine · DEUniversity Hospital Cologne · DEUniversity of Cologne · DE

Funding

Deutsche Sporthochschule Köln L-11-10011-238-102000
6 · The paper itself

Abstract

backgroundMultimodal agility-based exercise training (MAT) is a group-based exercise training framework for persons with multiple sclerosis (pwMS) with a potential to impact fatigue and fatigability. In a mixed-methods design, this study evaluated the feasibility of implementing MAT in an inpatient rehabilitation setting and the feasibility of a randomized controlled trial (RCT) study protocol with 'traditional' strength and endurance training (SET) as an active control condition. Secondarily, preliminary outcome data was acquired.

methodsPwMS with low to moderate disability and self-reported fatigue were randomly allocated to either MAT or SET when starting inpatient rehabilitation (4-6 weeks). The MAT-participants exercised in a group following a MAT-manual (sessions were gym- (5x/week) and pool-based (3x/week)). SET-participants exercised individually 5x/week on a cycle ergometer, and 3x/week on strength training machines. Feasibility assessments focused on processes, resources, management, time, and scientific domains. Assessed clinical outcomes at admission and discharge included perceived fatigue, motor and cognitive fatigability, cognitive performance, motor function, and balance confidence. Perceived fatigue was reassessed 1, 4, and 12 weeks after discharge. Feasibility was determined regarding predetermined progression criteria.

resultsTwenty-two participants were randomized. Both groups performed the minimum number of sessions (> 18), and retention was adequate (73-91%). SET-participants performed more sessions than MAT-participants (30.8 vs. 22.7) and stayed longer in the facility (34.2 vs. 31.6 days). Non-eligibility of admitted pwMS was high (74% non-eligible), mainly due to high EDSS and inability to attend pool-based sessions. Consequently, recruitment (1.8/month) was slower than the predetermined progression criterium. Baseline assessments took longer than required (only 50% completed within 3 days). Short-term fatigue reduction was similar for both groups. Motor fatigability also improved in both groups, whereas cognitive fatigability deteriorated. In MAT, average improvement in walking endurance (43.9 m) exceeded minimal important change values for individuals (> 26.9 m).

conclusionsProgressing to a definitive RCT necessitates adaptation of eligibility criteria. In the present design it will also be difficult to attain similar dosing of interventions. A multicenter RCT focused only on gym-based MAT might be another option to assess the effect of MAT. The primary outcome measure should be able to measure change in perceived fatigue more robustly.

trial registrationGerman Clinical Trials Register: DRKS00023943, date of registration: 23 September 2021.

Indexed as

Endurance TrainingMultiple SclerosisResistance TrainingExerciseExercise TherapyFatigueFeasibility StudiesHumansInpatientsAgilityExerciseFatigueMultiple sclerosisRehabilitation

Identifiers

PMID37898772
PMCPMC10612282
OpenAlexW4388001800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.